Literature DB >> 15906748

Need for guidelines in gastroenterology for the general practitioner.

Yaron Niv1.   

Abstract

General practitioners base their clinical strategy on evidence-based medicine and experience. When prospective randomized controlled studies have not provided an answer to a specific clinical question, or when common practice in a certain area is not well established, guidelines formulated by specialists with in-depth knowledge of the field are needed. Studies have shown that gastroenterology guidelines have improved the approach to Helicobacter pylori infection and the management of gastroesophageal reflux disease. Failure to use these guidelines by general practitioners can lead to diagnostic inconsistencies and faulty patient care. This is particularly important in Israel, where the heterogeneous patient and physician populations are characterized by differences in the interpretation of symptoms, disease prevalence, and education.

Entities:  

Mesh:

Year:  2005        PMID: 15906748     DOI: 10.1007/s10620-005-2643-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

Review 1.  Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

Authors:  M M Wolfe; D R Lichtenstein; G Singh
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

2.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 3.  Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity.

Authors:  M R Griffin; J M Scheiman
Journal:  Am J Med       Date:  2001-01-08       Impact factor: 4.965

4.  Evaluation of an evidence-based guideline for bronchiolitis.

Authors:  P H Perlstein; U R Kotagal; C Bolling; R Steele; P J Schoettker; H D Atherton; M K Farrell
Journal:  Pediatrics       Date:  1999-12       Impact factor: 7.124

Review 5.  Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.

Authors:  P Malfertheiner; F Mégraud; C O'Morain; A P S Hungin; R Jones; A Axon; D Y Graham; G Tytgat
Journal:  Aliment Pharmacol Ther       Date:  2002-02       Impact factor: 8.171

6.  Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial.

Authors:  F E Silverstein; D Y Graham; J R Senior; H W Davies; B J Struthers; R M Bittman; G S Geis
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

7.  Gastroesophageal reflux disease: a need for guidelines for the primary care physician.

Authors:  Yaron Niv; Shlomo Birkenfield
Journal:  Isr Med Assoc J       Date:  2002-09       Impact factor: 0.892

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.